Medicine and Dentistry
Vascular Smooth Muscle Cell
100%
Arteriogenesis
83%
Arteriole
66%
Heart
50%
Left Ventricle
50%
Therapeutic Procedure
33%
Cells
33%
Adult
33%
Marker
33%
Phenotype
33%
Perfusion
33%
Dimethyl Sulfoxide
33%
Cardiotoxicity
33%
N (2,3 Dihydroxypropoxy) 3,4 Difluoro 2 (2 Fluoro 4 Iodoanilino)benzamide
33%
Drug
16%
Chemotherapeutic Agent
16%
Evaluation Study
16%
In Vitro
16%
Tissues
16%
Immunohistochemistry
16%
Screening
16%
Cancer Treatment
16%
Combination Therapy
16%
Programmed Cell Death
16%
Differentiation
16%
Heart Function
16%
Gene
16%
Assessment
16%
Actin
16%
Coronary Artery
16%
Ischemia
16%
Cardiomyocyte
16%
Culture
16%
Heavy Meromyosin
16%
Short Course Therapy
16%
Heart Muscle Perfusion
16%
Immunology and Microbiology
Vascular Smooth Muscle Cell
100%
Artery Formation (Physiology)
83%
Arteriole
66%
Heart
50%
Pericyte
50%
Cells
33%
Mouse
33%
Phenotype
33%
Perfusion
33%
Tissues
16%
Screening
16%
Apoptosis
16%
Sample
16%
Coronary Artery
16%
Heavy Chain
16%
Gene
16%
Actin
16%
Differentiation
16%
Heart Function
16%
Heart Muscle Perfusion
16%
Biochemistry, Genetics and Molecular Biology
Artery Formation (Physiology)
83%
Pericyte
50%
Mouse
33%
Perfusion
33%
Phenotype
33%
Mural Cell
33%
Sample
16%
Nested Gene
16%
Screening
16%
Apoptosis
16%
Heart Function
16%
Heavy Chain
16%
Actin
16%
Myosin
16%
Immunostaining
16%
Heart Muscle Perfusion
16%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
50%
Mouse
33%
Dimethyl Sulfoxide
33%
Cardiotoxicity
33%
N (2,3 Dihydroxypropoxy) 3,4 Difluoro 2 (2 Fluoro 4 Iodoanilino)benzamide
33%
Drug
16%
Actin
16%
Ischemia
16%
Veterinary Science and Veterinary Medicine
Pericyte
50%
Mural Cell
33%
Ischemia
16%